// App-Quantinova.ai

PO1950 : Anti-IL-5 Therapy in Eosinophilic Granulomatosis with Polyangiitis (EGPA): An 18-Month Follow-Up Study of a Steroid-Sparing Therapeutic Approach

Researchers

Presenter

  • Egan Allyson�Catherine

Principal Investigators

  • Sivasothy Pasupathy

  • Gore RobinB

  • Owen CarolineMary

  • Jones RachelB

  • Smith RonaM

  • Willcocks LisaC

  • Burns StellaM

  • Jayne DavidR.W

Medical Centers

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • University of Cambridge Cambridge Cambridgeshire United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved